Lumbosacral intrathecal injections of replication-defective AD vector encoding for human IL-10 (AD-IL10) site-specifically induces high levels of human IL-10 protein in lumbosacral CSF; treatment with AD-IL10 reduced the development of tolerance to morphine during these days [200]. The gene discussed is IL10; the disease is Alzheimer disease.